1. Home
  2. IDYA vs PAX Comparison

IDYA vs PAX Comparison

Compare IDYA & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • PAX
  • Stock Information
  • Founded
  • IDYA 2015
  • PAX 1988
  • Country
  • IDYA United States
  • PAX Cayman Islands
  • Employees
  • IDYA N/A
  • PAX N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • PAX Investment Managers
  • Sector
  • IDYA Health Care
  • PAX Finance
  • Exchange
  • IDYA Nasdaq
  • PAX Nasdaq
  • Market Cap
  • IDYA 2.2B
  • PAX 2.1B
  • IPO Year
  • IDYA 2019
  • PAX 2021
  • Fundamental
  • Price
  • IDYA $24.27
  • PAX $13.73
  • Analyst Decision
  • IDYA Strong Buy
  • PAX Strong Buy
  • Analyst Count
  • IDYA 13
  • PAX 1
  • Target Price
  • IDYA $51.36
  • PAX $14.00
  • AVG Volume (30 Days)
  • IDYA 1.1M
  • PAX 518.8K
  • Earning Date
  • IDYA 08-05-2025
  • PAX 08-01-2025
  • Dividend Yield
  • IDYA N/A
  • PAX 6.28%
  • EPS Growth
  • IDYA N/A
  • PAX N/A
  • EPS
  • IDYA N/A
  • PAX 0.53
  • Revenue
  • IDYA $7,000,000.00
  • PAX $397,504,000.00
  • Revenue This Year
  • IDYA $101.44
  • PAX $4.76
  • Revenue Next Year
  • IDYA $263.37
  • PAX $4.18
  • P/E Ratio
  • IDYA N/A
  • PAX $26.36
  • Revenue Growth
  • IDYA N/A
  • PAX 26.52
  • 52 Week Low
  • IDYA $13.45
  • PAX $9.43
  • 52 Week High
  • IDYA $40.74
  • PAX $14.52
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 52.57
  • PAX 51.38
  • Support Level
  • IDYA $22.09
  • PAX $13.45
  • Resistance Level
  • IDYA $24.75
  • PAX $14.03
  • Average True Range (ATR)
  • IDYA 1.25
  • PAX 0.31
  • MACD
  • IDYA -0.13
  • PAX -0.00
  • Stochastic Oscillator
  • IDYA 40.05
  • PAX 70.33

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

Share on Social Networks: